Protriptyline

Protriptyline is a tricyclic antidepressant that is indicated in the treatment of depression only under close clinical supervision. TCAs are structurally similar to phenothiazines.

Chemical structure of Protriptyline
Mechanism
Curator reviewed
Primary indication
For the treatment of depression.Curator reviewed · 1 structured indication
Formula / weight
C19H21N · 263.3767 g/mol (avg)
First approval
Canada, 1966 · United States, 2000
Also known as
Amimetilina
Code names
MK-240

Resolves to

Structure
InChIKeyBWPIARFWQZKAIA-UHFFFAOYSA-NSMILESCNCCCC1C2=CC=CC=C2C=CC2=CC=CC=C12
Transporters

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
1,580Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
16Marketed productsAcross 2 countries and 9 labellers
Sign in
1ATC codeIncluding every combination product, plus 27 drug categories
Sign in
18+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Protriptyline, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account